Jenny L. Hardison, Ph.D. - Publications

Affiliations: 
2004 University of California, Irvine, Irvine, CA 
Area:
Immunology, Microbiology Biology, Molecular Biology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Ramos SJ, Hardison JL, Stiles LN, Lane TE, Walsh CM. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system. Autoimmunity. 40: 54-65. PMID 17364498 DOI: 10.1080/08916930600996700  0.596
2006 Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. Journal of Immunology (Baltimore, Md. : 1950). 177: 8372-80. PMID 17142734 DOI: 10.4049/Jimmunol.177.12.8372  0.568
2006 Hardison JL, Kuziel WA, Manning JE, Lane TE. Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. The Journal of Infectious Diseases. 193: 1584-8. PMID 16652288 DOI: 10.1086/503812  0.645
2006 Lane TE, Hardison JL, Walsh KB. Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system Current Topics in Microbiology and Immunology. 303: 1-27. PMID 16570854 DOI: 10.1007/978-3-540-33397-5_1  0.597
2006 Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, Manning JE. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infection and Immunity. 74: 135-43. PMID 16368966 DOI: 10.1128/Iai.74.1.135-143.2006  0.683
2006 Hardison JL, Wrightsman RA, Carpenter PM, Lane TE, Manning JE. The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infection and Immunity. 74: 125-34. PMID 16368965 DOI: 10.1128/Iai.74.1.125-134.2006  0.686
2006 Hardison JL, Nistor G, Gonzalez R, Keirstead HS, Lane TE. Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Experimental Neurology. 197: 420-9. PMID 16297915 DOI: 10.1016/J.Expneurol.2005.10.016  0.512
2006 Gonzalez R, Hardison JL, Glaser J, Liu MT, Lane TE, Keirstead HS. The chemokine CXCL10 as a therapeutic target in animal models of neuroinflammatory disease Letters in Drug Design and Discovery. 3: 683-688. DOI: 10.2174/157018006778631839  0.319
2004 Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 172: 4018-25. PMID 15034013 DOI: 10.4049/Jimmunol.172.7.4018  0.606
2004 Trifilo MJ, Montalto-Morrison C, Stiles LN, Hurst KR, Hardison JL, Manning JE, Masters PS, Lane TE. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. Journal of Virology. 78: 585-94. PMID 14694090 DOI: 10.1128/Jvi.78.2.585-594.2004  0.641
Show low-probability matches.